MedPath

IFEX PWS 2G/VIAL

IFEX PWS 2G/VIAL

Discontinued
DIN Number

00797235

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

bristol labs division of bristol-myers squibb

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00797235
AIG Number0120706003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AA06 IFOSFAMIDE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IFOSFAMIDEActive
Strength: 2 G / VIAL
Monograph: IFOSFAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.